000180198 001__ 180198
000180198 005__ 20240229145609.0
000180198 0247_ $$2doi$$a10.1186/s13046-022-02380-8
000180198 0247_ $$2pmid$$apmid:35655310
000180198 0247_ $$2ISSN$$a0392-9078
000180198 0247_ $$2ISSN$$a1756-9966
000180198 0247_ $$2altmetric$$aaltmetric:129210242
000180198 037__ $$aDKFZ-2022-01167
000180198 041__ $$aEnglish
000180198 082__ $$a610
000180198 1001_ $$0P:(DE-He78)54c23e22f76a7925b5ffeeae323bb5c9$$aLi, Xiaoya$$b0$$eFirst author
000180198 245__ $$a5'isomiR-183-5p|+2 elicits tumor suppressor activity in a negative feedback loop with E2F1.
000180198 260__ $$aLondon$$bBioMed Central$$c2022
000180198 3367_ $$2DRIVER$$aarticle
000180198 3367_ $$2DataCite$$aOutput Types/Journal article
000180198 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1654260226_3573
000180198 3367_ $$2BibTeX$$aARTICLE
000180198 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000180198 3367_ $$00$$2EndNote$$aJournal Article
000180198 500__ $$a#EA:B050#LA:B050#
000180198 520__ $$aMicroRNAs (miRNAs) and isomiRs play important roles in tumorigenesis as essential regulators of gene expression. 5'isomiRs exhibit a shifted seed sequence compared to the canonical miRNA, resulting in different target spectra and thereby extending the phenotypic impact of the respective common pre-miRNA. However, for most miRNAs, expression and function of 5'isomiRs have not been studied in detail yet. Therefore, this study aims to investigate the functions of miRNAs and their 5'isomiRs.The expression of 5'isomiRs was assessed in The Cancer Genome Atlas (TCGA) breast cancer patient dataset. Phenotypic effects of miR-183 overexpression in triple-negative breast cancer (TNBC) cell lines were investigated in vitro and in vivo by quantifying migration, proliferation, tumor growth and metastasis. Direct targeting of E2F1 by miR-183-5p|+2 was validated with a 3'UTR luciferase assay and linked to the phenotypes of isomiR overexpression.TCGA breast cancer patient data indicated that three variants of miR-183-5p are highly expressed and upregulated, namely miR-183-5p|0, miR-183-5p|+1 and miR-183-5p|+2. However, TNBC cell lines displayed reduced proliferation and invasion upon overexpression of pre-miR-183. While invasion was reduced individually by all three isomiRs, proliferation and cell cycle progression were specifically inhibited by overexpression of miR-183-5p|+2. Proteomic analysis revealed reduced expression of E2F target genes upon overexpression of this isomiR, which could be attributed to direct targeting of E2F1, specifically by miR-183-5p|+2. Knockdown of E2F1 partially phenocopied the effect of miR-183-5p|+2 overexpression on cell proliferation and cell cycle. Gene set enrichment analysis of TCGA and METABRIC patient data indicated that the activity of E2F strongly correlated with the expression of miR-183-5p, suggesting transcriptional regulation of the miRNA by a factor of the E2F family. Indeed, in vitro, expression of miR-183-5p was regulated by E2F1. Hence, miR-183-5p|+2 directly targeting E2F1 appears to be part of a negative feedback loop potentially fine-tuning its activity.This study demonstrates that 5'isomiRs originating from the same arm of the same pre-miRNA (i.e. pre-miR-183-5p) may exhibit different functions and thereby collectively contribute to the same phenotype. Here, one of three isomiRs was shown to counteract expression of the pre-miRNA by negatively regulating a transcriptional activator (i.e. E2F1). We speculate that this might be part of a regulatory mechanism to prevent uncontrolled cell proliferation, which is disabled during cancer progression.
000180198 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000180198 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000180198 650_7 $$2Other$$aCell cycle
000180198 650_7 $$2Other$$aE2F1
000180198 650_7 $$2Other$$aIsomiRs
000180198 650_7 $$2Other$$aMiR-183-5p
000180198 650_7 $$2Other$$aMicroRNAs
000180198 650_7 $$2Other$$aTriple-negative breast cancer
000180198 7001_ $$0P:(DE-He78)b48bfd64120195b64b5f11d32ce5ed5e$$aMichels, Birgitta$$b1$$eFirst author$$udkfz
000180198 7001_ $$0P:(DE-He78)9f278d85be398e41c9b9734b333938a3$$aTosun, Oyku Ece$$b2$$eFirst author$$udkfz
000180198 7001_ $$0P:(DE-He78)a6ddb0231bceb756854b9eae81bd15b2$$aJung, Janine$$b3
000180198 7001_ $$0P:(DE-He78)e2714b2b7b9feca561b10886869779c6$$aKappes, Jolane$$b4$$udkfz
000180198 7001_ $$0P:(DE-He78)b554e6f80c38fa4d900f57af91b734ed$$aIbing, Susanne$$b5
000180198 7001_ $$aNataraj, Nishanth Belugali$$b6
000180198 7001_ $$aSahay, Shashwat$$b7
000180198 7001_ $$0P:(DE-He78)0d37cc734b95fed555f2244d6fee6320$$aSchneider, Martin$$b8$$udkfz
000180198 7001_ $$0P:(DE-He78)4bc62c4328ee88a188151ce56b0f9f50$$aWörner, Angelika$$b9$$udkfz
000180198 7001_ $$0P:(DE-He78)c280f2119fb65dee659242ffb3c3318a$$aBecki, Corinna$$b10$$udkfz
000180198 7001_ $$aIshaque, Naveed$$b11
000180198 7001_ $$0P:(DE-He78)75e2afb3ea0812786cc551c10679b67d$$aFeuerbach, Lars$$b12$$udkfz
000180198 7001_ $$0P:(DE-He78)a5f5be3a0458fbc0017086b569fe7d75$$aHeßling, Bernd$$b13
000180198 7001_ $$0P:(DE-He78)daaed5a5b968028e6e95d273150d5ab1$$aHelm, Dominic$$b14$$udkfz
000180198 7001_ $$0P:(DE-He78)18218139eec55d83cf82679934e5cd75$$aWill, Rainer$$b15$$udkfz
000180198 7001_ $$aYarden, Yosef$$b16
000180198 7001_ $$0P:(DE-He78)799d978330dff449f8244947929a4518$$aMüller-Decker, Karin$$b17$$udkfz
000180198 7001_ $$0P:(DE-He78)f6bebe05e7a748d3cbf9f59659567d52$$aWiemann, Stefan$$b18$$udkfz
000180198 7001_ $$0P:(DE-He78)a2dde36c70db0249408e1d88843d17a9$$aKörner, Cindy$$b19$$eLast author$$udkfz
000180198 773__ $$0PERI:(DE-600)2430698-8$$a10.1186/s13046-022-02380-8$$gVol. 41, no. 1, p. 190$$n1$$p190$$tJournal of experimental & clinical cancer research$$v41$$x0392-9078$$y2022
000180198 909CO $$ooai:inrepo02.dkfz.de:180198$$pVDB
000180198 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)54c23e22f76a7925b5ffeeae323bb5c9$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000180198 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b48bfd64120195b64b5f11d32ce5ed5e$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000180198 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9f278d85be398e41c9b9734b333938a3$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000180198 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a6ddb0231bceb756854b9eae81bd15b2$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000180198 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e2714b2b7b9feca561b10886869779c6$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000180198 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b554e6f80c38fa4d900f57af91b734ed$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000180198 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0d37cc734b95fed555f2244d6fee6320$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000180198 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4bc62c4328ee88a188151ce56b0f9f50$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000180198 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c280f2119fb65dee659242ffb3c3318a$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000180198 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)75e2afb3ea0812786cc551c10679b67d$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000180198 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a5f5be3a0458fbc0017086b569fe7d75$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000180198 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)daaed5a5b968028e6e95d273150d5ab1$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000180198 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)18218139eec55d83cf82679934e5cd75$$aDeutsches Krebsforschungszentrum$$b15$$kDKFZ
000180198 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)799d978330dff449f8244947929a4518$$aDeutsches Krebsforschungszentrum$$b17$$kDKFZ
000180198 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f6bebe05e7a748d3cbf9f59659567d52$$aDeutsches Krebsforschungszentrum$$b18$$kDKFZ
000180198 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a2dde36c70db0249408e1d88843d17a9$$aDeutsches Krebsforschungszentrum$$b19$$kDKFZ
000180198 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000180198 9141_ $$y2022
000180198 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-05-04
000180198 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-05-04
000180198 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-05-04
000180198 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-05-04
000180198 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-05-04
000180198 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-17
000180198 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-17
000180198 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-02-14T16:18:49Z
000180198 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-02-14T16:18:49Z
000180198 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-02-14T16:18:49Z
000180198 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-17
000180198 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-17
000180198 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-17
000180198 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-17
000180198 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-17
000180198 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ EXP CLIN CANC RES : 2021$$d2022-11-17
000180198 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bJ EXP CLIN CANC RES : 2021$$d2022-11-17
000180198 9202_ $$0I:(DE-He78)B050-20160331$$kB050$$lB050 Molekulare Genomanalyse$$x0
000180198 9201_ $$0I:(DE-He78)B050-20160331$$kB050$$lB050 Molekulare Genomanalyse$$x0
000180198 9201_ $$0I:(DE-He78)B330-20160331$$kB330$$lAngewandte Bioinformatik$$x1
000180198 9201_ $$0I:(DE-He78)W120-20160331$$kW120$$lProteinanalyse$$x2
000180198 9201_ $$0I:(DE-He78)W420-20160331$$kW420$$lW420 Gruppe Müller-Decker$$x3
000180198 9200_ $$0I:(DE-He78)B050-20160331$$kB050$$lB050 Molekulare Genomanalyse$$x0
000180198 980__ $$ajournal
000180198 980__ $$aVDB
000180198 980__ $$aI:(DE-He78)B050-20160331
000180198 980__ $$aI:(DE-He78)B330-20160331
000180198 980__ $$aI:(DE-He78)W120-20160331
000180198 980__ $$aI:(DE-He78)W420-20160331
000180198 980__ $$aUNRESTRICTED